2-(Cyclohexyloxy)nicotinonitrile

Catalog No.: 
ACLFZJ579
CAS No.: 
1016812-22-8
Molecular Formula: 
C12H14N2O
Molecular Weight: 
202.26
2-(Cyclohexyloxy)nicotinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$355.00InquiryInquiry
1g97%$871.00InquiryInquiry
5g97%$2638.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Cyclohexyloxy)nicotinonitrile
IUPAC Name2-(cyclohexyloxy)nicotinonitrile
MDL No.MFCD09943149
Molecular FormulaC12H14N2O
Molecular Weight202.26
SMILESN#CC1=C(OC2CCCCC2)N=CC=C1
InChI KeyVVMPGKGYTJRBCO-UHFFFAOYSA-N
Synonym2-(cyclohexyloxy)nicotinonitrile;3-Cyano-2-cyclohexyloxypyridine, 97+%;3-Cyano-2-cyclohexyloxypyridine;3-Pyridinecarbonitrile, 2-(cyclohexyloxy)-
CAS No.1016812-22-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLFZJ579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFVTI206 route compound structure diagram
    ACFVTI2066602-54-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLFZJ579 route product structure diagram
    ACLFZJ5791016812-22-8
Inquiry

2. ACLFZJ579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCKM865 route compound structure diagram
    ACBCKM86520577-26-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLFZJ579 route product structure diagram
    ACLFZJ5791016812-22-8
Inquiry

3. ACLFZJ579 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLFZJ579 route product structure diagram
    ACLFZJ5791016812-22-8
Inquiry

Comments (0)